Filter
818
Text search:
infectious
substances
Featured
Recommendations
105
New Publications
189
Language
Document type
No document type
406
Guidelines
185
Studies & Reports
96
Manuals
64
Strategic & Response Plan
31
Training Material
19
Situation Updates
8
Fact sheets
5
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
India
36
South Africa
36
Kenya
32
Western and Central Europe
25
Nigeria
19
Ghana
19
Global
18
Ethiopia
16
Sierra Leone
15
Uganda
13
Zambia
13
Liberia
11
Tanzania
11
Eswatini/ Swaziland
9
Bangladesh
8
Namibia
8
Myanmar / Burma
8
Africa
7
Philippines
6
Nepal
6
Rwanda
6
Botswana
6
Eastern Europe
6
Guinea
5
Syria
5
Ukraine
5
Latin America and the Carribbean
5
Zimbabwe
4
Germany
4
Mozambique
4
Angola
4
Eastern Europe and Central Asia
4
Congo, Democratic Republic of
3
Cameroon
3
Indonesia
3
Brazil
3
North Macedonia
3
Lesotho
3
West and Central Africa
3
South–East Asia Region
3
Russia
3
Guinea-Bissau
2
USA
2
South Sudan
2
Malawi
2
Yemen
2
Middle East and North Africa
2
Western Pacific Region
2
Poland
2
Tajikistan
2
Georgia
2
United Kingdom
2
Burkina Faso
1
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Togo
1
Haiti
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Chad
1
Cambodia
1
Thailand
1
Singapore
1
Papua New Guinea
1
Sudan
1
Argentina
1
Peru
1
Switzerland
1
Serbia
1
Hungary
1
Sri Lanka
1
East and Southern Africa
1
Asia
1
Albania
1
Southern Africa
1
Estonia
1
Romania
1
Moldova
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Maldives
1
Mauritius
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
273
Clinical Guidelines
57
Public Health
38
Pharmacy & Technologies
37
Key Resources
33
Women & Child Health
21
Capacity Building
13
Protection & Security
1
Toolboxes
COVID-19
74
AMR
73
Mental Health
68
Rapid Response
66
HIV
51
TB
48
Pharmacy
47
Planetary Health
42
Ebola
32
Caregiver
26
NCDs
15
Specific Hazards
13
Conflict
10
Global Health Education
10
Zika
9
Natural Hazards
8
NTDs
8
Cholera
4
Refugee
4
Disability
3
Polio
2
Health Financing Toolbox
1
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug
...
Accessed: 07.11.2019
Antimicrobial resistance has become a serious public health threat for effective treatment of an ever increasing range of infections caused by bacteria, parasites, viruses and fungi. When infections can no longer be treated by first-line antibiotics, other antibiotics must be used, which are both mo
...
Reporting period January 2015 – December 2015
Bucharest, April 2016
Healthcare-associated infections (HAI) are a significant burden globally, with millions of patients affected each year. These infections affect both high- and limited-resource healthcare settings, but in limited-resource settings, rates are approximately twice as high as high-resource settings (15 o
...
Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus
A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl
...
This policy brief identifies and explains the main reasons behind the rise of antimicrobial resistance (AMR) associated with improper use of antibiotics in the livestock sector. Focusing on the low- and middle- income country setting, this brief provides recommendations for a deliberated policy stra
...
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in Production animals – Cattle and Pigs,
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial
...
Note: this list is provided as an indicative list only. It does not have legal status. Example list from Ethiopia
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup
...
Ghana's attempt to regulate health care waste management started in 2002 with the development of guidelines on health care waste manage-ment by the Environmental Protection Agency (EPA). In 2006, the Ghana Health Service (GHS) also developed the Health Care Waste Management Policy and Guidelines as
...
This section provides general information on HCW and key elements of management procedures that are essential to know before developing a HCWM plan.
Injection Safety and Safe Disposal of Medical Waste National Communication Strategy and Health Care Waste Management Standard
Operating Procedures (SOPs).
The overall objective of the consultancy was to review and align the three national technical and communication guiding documents on HCWM to th
...
These guidelines provide recommendations for the non-pharmacological aspects of infection prevention and control for acute respiratory diseases (ARD) in health care. Administrative and infection controls, including early detection, isolation and reporting, and establishment of infection control infr
...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t
...
